Emerging Company Profile
How D3 Bio is building its biomarker-driven pipeline
Emerging Company Profile: D3 Bio’s Chen on the start-up’s internal pipeline, plans for in-licensing
D3 Bio’s George Chen on the Shanghai start-up’s internal pipeline and plans for in-licensing.
Dec 9, 2020 | 12:08 AM GMT
George Chen’s D3 Bio is prioritizing its internal pipeline so it can be choosy about